ArticleJournal of cellular and molecular medicine2018

Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.

Katerina Kapodistria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.